Fertility preservation methods in breast cancer

Breast Care

Volumn 7, Issue 3, 2012, Pages 197-202

  Peccatori, Fedro A ^a   Del Pup, Lino ^b   Salvagno, Francesca ^c   Guido, Maurizio ^d   Sarno, Maria A ^a   Revelli, Alberto ^c   Delle Piane, Luisa ^c   Dolfin, Elisabetta ^c   Franchi, Dorella ^a   Molinari, Emanuela ^c   Immediata, Valentina ^d   Chiavari, Leonora ^a   Vucetich, Alessandra ^e   Borini, Andrea ^f  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^b CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d CATHOLIC UNIVERSITY   (Italy)

^e Centro per la Procreazione Medicalmente Assistita   (Italy)

^f Tecnobios Procreazione   (Italy)

Author keywords

Breast cancer; Chemotherapy; Cryopreservation; Fertility preservation; Oocytes; Ovarian failure

Indexed keywords

ANTINEOPLASTIC AGENT; BUSULFAN; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GONADORELIN DERIVATIVE; GOSERELIN; IFOSFAMIDE; MELPHALAN; METHOTREXATE; PACLITAXEL; TAMOXIFEN; TRASTUZUMAB; TRIPTORELIN; VINCRISTINE;

AMENORRHEA; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL EFFECTIVENESS; CRYOPRESERVATION; DRUG MECHANISM; HIGH RISK POPULATION; HUMAN; IN VITRO OOCYTE MATURATION; OOCYTE MATURATION; OVARY; OVARY DISEASE; PHARMACOLOGICAL PROCEDURES; PREGNANCY; PRIORITY JOURNAL; PROTECTION; REPRODUCTION; REPRODUCTIVE PROCEDURE; REVIEW; RISK ASSESSMENT; TREATMENT DURATION;

EID: 84863931039     PISSN: 16613791     EISSN: 16613805     Source Type: Journal    
DOI: 10.1159/000339671     Document Type: Review

References (63)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ: Cancer statistics 2009. CA Cancer J Clin 2009;59:225-249
2. Murk W, Seli E: Fertility preservation as a public health issue: An epidemiological perspective. Curr Opin Obstet Gynecol 2011;23:143-150.
3. Lawrenz B, Jauckus J, Kupka MS, Strowitzki T, von Wolff M: Fertility preservation in >1,000 patients: Patient's characteristics, spectrum, efficacy and risks of applied preservation techniques. Arch Gynecol Obstet 2011;283:651-656
4. Peccatori FA, Azim HA Jr: Pregnancy in breast cancer survivors: A need for proper counseling. Breast 2009;18:337-338.
5. Lee SJ, Schover LR, Partridge AH, Patrizio P, Wallace WH, Hagerty K, Beck LN, Brennan LV, Oktay K: American Society of Clinical Oncology Recommendations on Fertility Preservation in People Treated for Cancer. Clin Oncol 2006;18: 2917-2931
6. American Society for Reproductive Medicine: Fertility preservation and reproduction in cancer patients. The Etichs Committee of the American Society for Reproductive Medicine. Fertil Steril 2005;83:1622-1628
7. von Wolff M, Montag M, Dittrich R, Denschlag D, Nawroth F, Lawrenz B: Fertility preservation in women - A practical guide to preservation techniques and therapeutic strategies in breast cancer, Hodgkin's lymphoma and borderline ovarian tumours by the fertility preservation network Ferti- PROTEKT. Arch Gynecol Obstet 2011;284:427-435
8. Wallace WH, Kelsey TW: Human ovarian reserve from conception to the menopause. PLoS One 2010;5:e8772
9. Alshami HA, Kadasne AR, Khalfan M, Iqbal SZ, Mirghani HM: Pregnancy outcome in late maternal age in a high-income developing country. Arch Gynecol Obstet 2011;284:1113-1116
10. Hansen KR, Hodnett GM, Knowlton N, Craig LB: Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril 2011;95:170-175
11. Koyama H, Wada T, Nishizawa Y, Iwanaga T, Aoki Y: Cyclophosphamide- induced ovarian failure and its therapeutic significance in patients with breast cancer. Cancer 1977;39:1403-1409
12. Sukumvanich P, Case LD, Van Zee K, Singletary SE, Paskett ED, Petrek JA, Naftalis E, Naughton MJ: Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: A prospective study. Cancer 2010;116:3102-3111
13. Familiari G, Caggiati A, Nottola SA, Ermini M, Di Benedetto MR, Motta PM: Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod 1993;8:2080-2087
14. Oktem O, Oktay K: A novel ovarian xenografting model to characterize the impact of chemotherapy agents on human primordial follicle reserve. Cancer Res 2007;67:10159-10162.
15. Meirow D, Dor J, Kaufman B, Shrim A, Rabinovici J, Schiff E, Raanani H, Levron J, Fridman E: Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury. Hum Reprod 2007;22:1626-1633
16. Azim HA Jr, Peccatori FA, Liptrott SJ, Catania C, Goldhirsch A: Breast cancer and pregnancy: How safe is trastuzumab? Nat Rev Clin Oncol 2009;6:367-370
17. Partridge AH, Ruddy KJ, Gelber S, Schapira L, Abusief M, Meyer M, Ginsburg E: Ovarian reserve in women who remain premenopausal after chemotherapy for early stage breast cancer. Fertil Steril 2010;94:638-644
18. Pagani O, Partridge A, Korde L, Badve S, Bartlett J, Albain K, Gelber R, Goldhirsch A: Breast International Group-North American Breast Cancer Group Endocrine Working Group. Pregnancy after reast cancer: If you wish, ma'am. Breast Cancer Res Treat 2011;129:309-317
19. Fox KR, Scialla J, Moore H: Preventing chemotherapy- related amenorrhea using leuprolide during adjuvant chemotherapy for early-stage breast cancer. Proc Am Soc Clin Oncol 2003;22:13
20. Del Mastro L, Catzeddu T, Boni L, Bell C, Sertoli MR, Bighin C, Clavarezza M, Testa D, Venturini M: Prevention of chemotherapy-induced menopause by temporary ovarian suppression with goserelin in young, early breast cancer patients. Ann Oncol 2006;17:74-78
21. Recchia F, Saggio G, Amiconi G, Di Blasio A, Cesta A, Candeloro G, Rea S: Gonadotropinreleasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma. Cancer 2006;106:514-523
22. Urruticoechea A, Arnedos M, Walsh G, Dowsett M, Smith IE: Ovarian protection with goserelin during adjuvant chemotherapy for pre-menopausal women with early breast cancer (EBC). Breast Cancer Res Treat 2008; 110:411-416
23. Badawy A, Elnashar A, El-Ashry M, Shahat M. Gonadotropin-releasing hormone agonists for prevention of chemotherapy-induced ovarian damage: Prospective randomized study. Fertil Steril 2009; 91:694-697
24. Del Mastro L, Boni L, Michelotti A, Gamucci T, Olmeo N, Gori S, Giordano M, Garrone O, Pronzato P, Bighin C, Levaggi A, Giraudi S, Cresti N, Magnolfi E, Scotto T, Vecchio C, Venturini M: Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: A randomized trial. JAMA 2011;306:269-276
25. Gerber B, von Minckwitz G, Stehle H, Reimer T, Felberbaum R, Maass N, Fischer D, Sommer HL, Conrad B, Ortmann O, Fehm T, Rezai M, Mehta K, Loibl S. German Breast Group Investigators: Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: The GBG 37 ZORO study. J Clin Oncol 2011;29:2334-2341
26. Munster PN, Moore AP, Ismail-Khan R, Cox CE, Lacevic M, Gross-King M, Xu P, Carter WB, Minton SE; Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. J Clin Oncol 2012;30:533-538
27. Martinez-Madrid B, Camboni A, Dolmans MM, Nottola S, Van Langendonckt A, Donnez J: Apoptosis and ultrastructural assessment after cryopreservation of whole human ovaries with their vascular pedicle. Fertil Steril 2007;87:1153-1165
28. Jadoul P, Donnez J, Dolmans MM, Squifflet J, Lengele B, Martinez-Madrid B: Laparoscopy ovariectomy for whole human ovary cryopreservation: Technical aspects. Fertil Steril 2007;87:971-975
29. Akar ME, Carrello AJ, Jennell JL, Yalcinkaya TM: Robotic-assisted laparoscopic ovarian tissue transplantation. Fertil Steril 2011;95:1120
30. Andersen CY, Rosendahl M, Byskov AG, Loft A, Ottosen C, Dueholm M, Schmidt KL, Andersen AN, Ernst E: Two successful pregnancies following autotransplantation of frozen/thawed ovarian tissue. Hum Reprod 2008;23:2266-2272
31. Gook DA, Edgar DH, Stern C: Effect of cooling rate and dehydration regimen on the histological appearance of human ovarian cortex following cryopreservation in 1,2-propanediol. Hum Reprod 1999;14:2061-2068
32. Amorim CA, Curaba M, Van Langendonckt A, Dolmans MM, Donnez J: Vitrification as an alternative means of cryopreserving ovarian tissue. Reprod Biomed Online 2011;23:160-186
33. Meirow D, Fasouliotis SJ, Nugent D, Schenker JG, Gosden RG, Rutherford AJ: A laparoscopic technique for obtaining ovarian cortical biopsy specimens for fertility conservation in patients with cancer. Fertil Steril 1999;71:948-951.
34. Schröder CP, Timmer-Bosscha H, Wijchman JG, de Leij LF, Hollema H, Heineman MJ, de Vries EG: An in vitro model for purging of tumour cells from ovarian tissue. Hum Reprod 2004;19:1069-1075
35. Donnez J, Jadoul P, Squifflet J, Van Langendonckt A, Donnez O, Van Eyck AS, Marinescu C, Dolmans MM: Ovarian tissue cryopreservation and transplantation in cancer patients. Best Pract Res Clin Obstet Gynaecol 2010;24:87-100
36. Donnez J, Dolmans MM: Preservation of fertility in females with haematological malignancy. Br J Haematol 2011;154:175-184
37. Silber S, Kagawa N, Kuwayama M, Golden R: Duration of fertility after fresh and frozen ovary transplantation. Fertil Steril 2010;94:2191-2196
38. Revel A, Laufer N, Ben Meir A, Lebovich M, Mitrani E: Micro-organ ovarian transplantation enables pregnancy: A case report. Hum Reprod 2011;26:1097-1103
39. Dittrich R, Lotz L, Keck G, Hoffmann I, Mueller A, Beckmann MW, van der Ven H, Montag M: Live birth after ovarian tissue autotransplantation following overnight transportation before cryopreservation. Fertil Steril 2012;97: 387-390
40. Oktay K, Buyuk E, Veeck L, Zaninovic N, Xu K, Takeuchi T, Opsahl M, Rosenwaks Z: Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;363:837-840
41. Wang X, Catt S, Pangestu M, Temple-Smith P: Successful in vitro culture of pre-antral follicles derived from vitrified murine ovarian tissue: Oocyte maturation, fertilization, and live births. Reproduction 2011;141:183-191
42. Magistrini M, Szollosi D: Effects of cold and of isopropyl-N- phenylcarbamate on the second meiotic spindle of mouse oocytes. Eur J Cell Biol 1980;22:699-707
43. Borini A, Bonu MA, Coticchio G, Bianchi V, Cattoli M, Flamigni C: Pregnancies and births after oocyte preservation. Fert Steril 2004;82:601-605
44. Fabbri R, Porcu E, Marsella T, Rocchetta G, Venturoli S, Flamigni C: Human oocyte cryopreservation: New perspectives regarding oocyte survival. Hum Reprod 2001;16:411-416
45. Borini A, Sciajno R, Bianchi V, Sereni E, Flamigni C, Coticchio G: Clinical outcome of oocyte preservation after slow cooling with a protocol utilizing a high sucrose concentration. Hum Reprod 2006;21:512-517.
46. Levi Setti PE, Albani E, Novara PV, Cesana A, Morreale G: Cryopreservation of supernumerary oocytes in IVF/ICSI cycles. Hum Reprod 2006;21:370-375
47. Bianchi V, Coticchio G, DistraIs V, Di Giusto N, Flamigni C, Borini A: Differential sucrose concentration during dehydration (0.2 mol/l) and rehydration (0.3 mol/l) increases the implantation rate of frozen human oocytes. Reprod Biomed Online 2007;14:64-71
48. Rall WF, Fathy GM: Ice-free cryopreservation of mouse embryos at -196 °C vitrification. Nature 1985;313:573
49. Kuleshova L, Gianaroli L, Magli C, Ferraretti A, Trounson A: Birth following vitrification of a small number of human oocytes. Hum Reprod 1999;14:3077-3079
50. Kuwayama M, Vajta G, Kato O, Leibo SP: Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 2005;11:300-308
51. Smith G, Serafini C, FioravanI J, Yadid I, Coslovsky M, Hassun P, Alegretti JR, Motta EL: Prospective randomized comparison of human oocyte cryopreservation with slow-rate freezing or vitrification. Fertil Steril 2010;94:2088-2095
52. Grifo J, Noyes N: Delivery rate using cryopreserved oocytes is comparable to conventional in vitro fertilization using fresh oocytes: Potential fertility preservation for female cancer patients. Fertil Steril 2010;93:391-396
53. Ubaldi F, Anniballo R, Romano S, Baroni E, Albricci L, Colamaria S, Capalbo A, Sapienza F, Vajta G, Rienzi L: Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program. Hum Reprod 2010;25:1199-1205
54. The Practice Committee of the American Society for Reproductive Medicine. Ovarian tissue and oocyte cryopreservation. Fertil Steril 2004;82:993-998
55. Oktay K, Cil AP, Bang H: Efficiency of oocyte cryopreservation: A meta-analysis. Fertil Steril 2006;86:70-80
56. Oktay K, Buyuk E, Akar Z, Rosenwaks N, Libertella N: Fertility preservation in breast cancer patients: A prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. Fertil Steril 2004;82:s1
57. Oktay K: Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility reservation. J Clin Oncol 2005;23:3858-3859
58. Cha KY, Koo JJ, Ko JJ, Choi DH, Han SY, Yoon TK: Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril 1991;55:109-113
59. Rao GD, Tan SL: In vitro maturation of oocytes. Semin Reprod Med 2005;23:242-247.
60. Shalom-Paz E, Almog B, Shehata F, Huang J, Holzer H, Chian RC, Son WY, Tan SL: Fertility preservation for breast-cancer patients using IVM followed by oocyte or embryo vitrification. Reprod Biomed Online. 2010;21:566-571
61. Picton HM, Harris SE, Muruvi W, Chambers EL: The in-vitro growth and maturation of follicles. Reproduction 2008;136:703-715
62. White YA, Woods DC, Takai Y, Ishihara O, Seki H, Tilly JL: Oocyte formation by mitotically active germ cells purified from ovaries of reproductive- age women. Nat Med. 2012;18:413-421
63. Azim HA Jr, de Azambuja E, Colozza M, Bines J, Piccart MJ: Long-term toxic effects of adjuvant chemotherapy in breast cancer. Ann Oncol 2011;22:1939-1947